Uloric
chronic, symptomatic Hyperuricemia, Arthritis, Gouty, allopurinol
Treatment
3 FDA approvals
0 Active Studies for Uloric
Treatment for
chronic, symptomatic Hyperuricemia
What is Uloric
Febuxostat
The Generic name of this drug
Treatment Summary
Febuxostat is a medication used to treat high levels of uric acid in the blood that can cause gout. Gout is a type of arthritis caused by the buildup of uric acid crystals in or around a joint, causing inflammation and long-term damage to bones, tissues, and other organs. Febuxostat works by blocking an enzyme responsible for the production of uric acid, which helps to lower the amount of uric acid in the blood. In 2019, the FDA added a black box warning to febuxostat due to an increased risk of cardiovascular-related death in patients with existing cardiovascular disease when
Uloric
is the brand name
Uloric Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Uloric
Febuxostat
2009
51
Approved as Treatment by the FDA
Febuxostat, also known as Uloric, is approved by the FDA for 3 uses which include Arthritis, Gouty and allopurinol .
Arthritis, Gouty
Helps manage Gouty Arthritis
allopurinol
Helps manage inadequate response to or intolerant of allopurinol
chronic, symptomatic Hyperuricemia
Helps manage chronic, symptomatic Hyperuricemia
Effectiveness
How Uloric Affects Patients
Febuxostat is a medication that helps to lower levels of uric acid in the body. When taken daily in doses of 40-80 mg, it can reduce the 24-hour mean serum uric acid concentrations by 40-55%. This drug is different from allopurinol and oxypurinol as it does not affect other enzymes related to the production of purines and pyrimidines in the body. Taking febuxostat may cause gout flares.
How Uloric works in the body
Gout is a type of arthritis caused by uric acid crystals forming around the joints. Febuxostat helps treat gout by blocking an enzyme called XOR. This enzyme helps make uric acid which causes gout. In some cases, XOR can also be converted into a form which produces harmful chemicals called reactive oxygen species. Febuxostat helps block the conversion of XOR, reducing the amount of reactive oxygen species produced and decreasing inflammation. In some cases, febuxostat has also been shown to reduce oxidative stress and renal injury in a rat model.
When to interrupt dosage
The suggested measure of Uloric is contingent upon the diagnosed disorder, such as chronic, symptomatic Hyperuricemia, Gouty Arthritis and allopurinol. The quantity of dosage varies, in accordance with the administration technique (e.g. Oral or Tablet, coated) specified in the table beneath.
Condition
Dosage
Administration
chronic, symptomatic Hyperuricemia
80.0 mg, , 40.0 mg, 120.0 mg
, Oral, Tablet - Oral, Tablet, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Tablet, coated
Arthritis, Gouty
80.0 mg, , 40.0 mg, 120.0 mg
, Oral, Tablet - Oral, Tablet, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Tablet, coated
allopurinol
80.0 mg, , 40.0 mg, 120.0 mg
, Oral, Tablet - Oral, Tablet, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Tablet, coated
Warnings
Uloric Contraindications
Condition
Risk Level
Notes
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
There are 20 known major drug interactions with Uloric.
Common Uloric Drug Interactions
Drug Name
Risk Level
Description
Azathioprine
Major
The metabolism of Azathioprine can be decreased when combined with Febuxostat.
Didanosine
Major
The serum concentration of Didanosine can be increased when it is combined with Febuxostat.
Mercaptopurine
Major
The serum concentration of Mercaptopurine can be increased when it is combined with Febuxostat.
Ozanimod
Major
Febuxostat may decrease the excretion rate of Ozanimod which could result in a higher serum level.
Pegloticase
Major
The risk or severity of adverse effects can be increased when Febuxostat is combined with Pegloticase.
Uloric Toxicity & Overdose Risk
The most toxic dose of febuxostat that has been reported in humans is 1.82mg/kg taken over a 14 day period. In mice, the toxic dose is 300mg/kg, 3200mg/kg in rabbits, and 980mg/kg in rats. No serious side effects were observed in healthy people who took up to 300mg of febuxostat per day for 7 days. If someone takes too much febuxostat, there is no known antidote and they should just be given supportive care.
Uloric Novel Uses: Which Conditions Have a Clinical Trial Featuring Uloric?
At present, 0 active clinical trials are examining the potential of Uloric to ameliorate allopurinol, chronic symptomatic Hyperuricemia and Gouty Arthritis.
Condition
Clinical Trials
Trial Phases
allopurinol
0 Actively Recruiting
chronic, symptomatic Hyperuricemia
0 Actively Recruiting
Arthritis, Gouty
0 Actively Recruiting
Uloric Reviews: What are patients saying about Uloric?
5
Patient Review
2/9/2016
Uloric for Treatment to Prevent Gout
5
Patient Review
1/17/2016
Uloric for Gout
5
Patient Review
10/31/2016
Uloric for Treatment to Prevent Gout
5
Patient Review
4/29/2017
Uloric for Gout
5
Patient Review
11/29/2016
Uloric for Gout
5
Patient Review
3/15/2016
Uloric for Gout
5
Patient Review
11/21/2019
Uloric for Gout
5
Patient Review
10/12/2021
Uloric for Treatment to Prevent Gout
5
Patient Review
10/16/2018
Uloric for Gout
5
Patient Review
11/3/2014
Uloric for Gout
3
Patient Review
5/6/2017
Uloric for Treatment to Prevent Gout
1.3
Patient Review
10/27/2015
Uloric for Gout
1.3
Patient Review
4/6/2015
Uloric for Gout
1
Patient Review
2/2/2015
Uloric for Gout
Patient Q&A Section about uloric
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is Uloric used for?
"Febuxostat is a drug that lowers uric acid levels in people who have gout. It works by reducing the amount of uric acid that the body produces. High levels of uric acid can cause gout."
Answered by AI
Is Uloric better than allopurinol?
"Takeda's clinical trials found that 80mg and 40mg doses of Uloric worked better and at least as well as allopurinol, respectively. Uloric is excreted much less through urine than allopurinol, making it a safer option for patients with kidney problems."
Answered by AI
Should I take Uloric during a gout attack?
"Uloric was a first-line treatment for gout in adults for almost 10 years, but in 2019 the U.S. Food and Drug Administration concluded that the drug presents a higher risk of death than a competing medicine and should not be used as the first choice for gout treatment."
Answered by AI